344.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com UK
West Pharmaceutical stock gains as UBS lifts price target to USD 415 - ad-hoc-news.de
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical stock heads before the bell after a 0.8 percent drop - ad-hoc-news.de
West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media
West Pharmaceutical stock gains after strong Q2 figures - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - indexbox.io
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - ad-hoc-news.de
West Pharma Sets September Investor Conference Appearances - MyChesCo
West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - ad-hoc-news.de
West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS
West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS
West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc. (WST) Peer Comparison – Compare with Others - valueresearchonline.com
16,794 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Cibc World Market Inc. - MarketBeat
West to Participate in Upcoming Investor Conferences - PR Newswire
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. (WPS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock holds firm after Q2 beat - Ad-hoc-news.de
NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,440 West Pharmaceutical Services, Inc. $WST - MarketBeat
2,043,823 Shares in West Pharmaceutical Services, Inc. $WST Bought by Bank of New York Mellon Corp - MarketBeat
West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative - Yahoo Finance
West Pharmaceutical stock holds firm as analysts lift targets - Ad-hoc-news.de
Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Generation Investment Management LLP Invests $728.17 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
410,699 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Deutsche Bank AG - MarketBeat
BlackRock Inc. Buys Shares of 6,651,784 West Pharmaceutical Services, Inc. $WST - MarketBeat
Join Class Action to Recover Losses from West Pharmaceutical Serv - The National Law Review
West Pharmaceutical stock steadies after institutional buying as shares trade near 52-week highs - Ad-hoc-news.de
Meeder Asset Management Inc. Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Pallas Capital Advisors LLC Acquires New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical Services (WST): Analyst Consensus And 15.83% Potential Upside - DirectorsTalk Interviews
Is West Pharmaceutical Services (WST) Undervalued After Its Run to $349.42? - Sahm
West Pharmaceutical Services (WST) Holds Above $349 as Shares Edge Higher — Key Levels in FocusMcClellan Summation - vinanet.vn
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally? - Yahoo Finance
West Pharmaceutical (WST) Upgraded to Buy: Here's Why - Yahoo Finance
West Pharmaceutical Services, Inc.: Target Price Consensus and Analysts Recommendations | WST | US9553061055 - marketscreener.com
Zacks Research Has Optimistic Outlook of WST Q3 Earnings - MarketBeat
West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at Zacks Research - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):